Despite the limited follow-up, repeated intravitreal injections of either 1.25 mg or 2.5 mg of bevacizumab appears to be safe and well tolerated during the 1st year.

No abstract

Retinopathy of prematurity (ROP) is one of the leading causes of preventable blindness in children worldwide. Middle-income nations are currently experiencing epidemic levels of ROP, because greater access to neonatal intensive care units has improved survival rates of premature infants, but without sophisticated oxygen regulation. The epidemiology, screening infrastructure, treatment options, and challenges that these countries face are often tied to unique local socioeconomic, cultural, geopolitical, and medical factors. We present an overview and narratives of the current state of ROP in eight countries that are or soon will be experiencing ROP epidemics

Objective To identify patterns of inter-expert discrepancy in plus disease diagnosis in retinopathy of prematurity (ROP). Design We developed two datasets of clinical images of varying disease severity (100 images and 34 images) as part of the Imaging and Informatics in ROP study, and determined a consensus reference standard diagnosis (RSD) for each image, based on 3 independent image graders and the clinical exam. We recruited 8 expert ROP clinicians to classify these images and compared the distribution of classifications between experts and the RSD. Subjects, Participants, and/or Controls Images obtained during routine ROP screening in neonatal intensive care units. 8 participating experts with >10 years of clinical ROP experience and >5 peer-reviewed ROP publications. Methods, Intervention, or Testing Expert classification of images of plus disease in ROP. Main Outcome Measures Inter-expert agreement (weighted kappa statistic), and agreement and bias on ordinal classification between experts (ANOVA) and the RSD (percent agreement). Results There was variable inter-expert agreement on diagnostic classifications between the 8 experts and the RSD (weighted kappa 0 – 0.75, mean 0.30). RSD agreement ranged from 80 – 94% agreement for the dataset of 100 images, and 29 – 79% for the dataset of 34 images. However, when images were ranked in order of disease severity (by average expert classification), the pattern of expert classification revealed a consistent systematic bias for each expert consistent with unique cut points for the diagnosis of plus disease and pre-plus disease. The two-way ANOVA model suggested a highly significant effect of both image and user on the average score (P<0.05, adjusted R2=0.82 for dataset A, and P< 0.05 and adjusted R2 =0.6615 for dataset B). Conclusions and Relevance There is wide variability in the classification of plus disease by ROP experts, which occurs because experts have different “cut-points” for the amounts of vascular abnormality required for presence of plus and pre-plus disease. This has important implications for research, teaching and patient care for ROP, and suggests that a continuous ROP plus disease severity score may more accurately reflect the behavior of expert ROP clinicians, and may better standardize classification in the future.

OBJECTIVE:To evaluate the clinical utility of a quantitative deep-learning derived vascular severity score for retinopathy of prematurity (ROP) by assessing its correlation with clinical ROP diagnosis and by measuring clinician agreement in applying a novel scale. DESIGN:Analysis of existing database of posterior pole fundus images and corresponding ophthalmoscopic examinations using two methods of assigning a quantitative scale to vascular severity. SUBJECTS AND PARTICIPANTS: Images were from clinical exams of patients in theImaging & Informatics in ROP consortium. 4 ophthalmologists and 1 study coordinator evaluated vascular severity on a 1-9 scale. METHODS:A quantitative vascular severity score (1-9) was applied to each image using a deep learning algorithm. A database of 499 images was developed for assessment of interobserver agreement. MAIN OUTCOME MEASURES: Distribution of deep learning derived vascular severityscores with the clinical assessment of zone (I,II,III), stage (0,1,2,3) and extent (<3, 3-6, >6 clock hours) of stage 3 evaluated using multivariable linear regression. Weighted kappa and Pearson correlation coefficients for inter-observer agreement on 1-9 vascular severity scale. RESULTS:For deep learning analysis, a total of 6344 clinical examinations were analyzed. A higher deep learning derived vascular severity score was associated with more posterior disease, higher disease stage, and higher extent of stage 3 disease (P<.001 for all). For a given ROP stage, the vascular severity score was higher in zone I than zone II or III (P<.001). For a given number of clock hours of stage 3, the severity score was higher in zone I than zone II (P=.03 in zone I and P<.001 in zone II). Multivariable regression found zone, stage, and extent were all independently associated with the severity score (P<.001 for all). For inter-observer agreement, mean (±Standard Deviation [SD]) weighted kappa was 0.67 (±0.06) and Pearson Correlation coefficient (±SD) was 0.88 (±.04) on the use of a 1-9 vascular severity scale. CONCLUSIONS:A vascular severity scale for ROP appears feasible for clinical adoption, corresponds with current international classification of ROP severity, and facilitates the use of objective technology such as deep learning to improve consistency of ROP diagnosis.

No abstract

No abstract

COVID-19, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), affects people of all ages. The virus can cause multiple systemic infections, principally in the respiratory tract, as well as microvascular damage. Ocular manifestations of COVID-19 are uncommon in adults and children. We describe ophthalmic manifestations in newborns detected by slit-lamp examination, fundus examination, and fluorescein angiography. All patients showed edema and hemorrhagic conjunctivitis; fundus examinations revealed cotton wool spots and vitreous hemorrhage, and microvascular damage manifested as patchy choroidal filling, peripapillary hyperfluorescence, delayed retinal filling and venous laminar flow, and boxcarring on fluorescein angiography.